These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 28449421)

  • 21. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
    Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
    World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathological role of microRNAs and inflammation in colon carcinogenesis.
    Zhang L; Fan XM
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):174-9. PubMed ID: 25154001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Updated Review of the Pre-Clinical Role of microRNAs and their Contribution to Colorectal Cancer.
    Dastmalchi N; Safaralizadeh R; Teimourian S
    Curr Mol Med; 2022; 22(10):851-859. PubMed ID: 34961460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From strings to signals: Unraveling the impact of miRNAs on diagnosis, and progression of colorectal cancer.
    Mohammed OA
    Pathol Res Pract; 2023 Nov; 251():154857. PubMed ID: 37804545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
    Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-coding landscapes of colorectal cancer.
    Ragusa M; Barbagallo C; Statello L; Condorelli AG; Battaglia R; Tamburello L; Barbagallo D; Di Pietro C; Purrello M
    World J Gastroenterol; 2015 Nov; 21(41):11709-39. PubMed ID: 26556998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-146a promote cell migration and invasion in human colorectal cancer via carboxypeptidase M/src-FAK pathway.
    Lu D; Yao Q; Zhan C; Le-Meng Z; Liu H; Cai Y; Tu C; Li X; Zou Y; Zhang S
    Oncotarget; 2017 Apr; 8(14):22674-22684. PubMed ID: 28186967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs: promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis.
    Hur K
    BMB Rep; 2015 Apr; 48(4):217-22. PubMed ID: 25603797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer.
    Rahmani F; Avan A; Hashemy SI; Hassanian SM
    J Cell Physiol; 2018 Feb; 233(2):811-817. PubMed ID: 28266708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
    Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
    Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis.
    Chen B; Xia Z; Deng YN; Yang Y; Zhang P; Zhu H; Xu N; Liang S
    Open Biol; 2019 Jan; 9(1):180212. PubMed ID: 30958116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenetic and clinical relevance of microRNAs in colorectal cancer.
    Valeri N; Croce CM; Fabbri M
    Cancer Genomics Proteomics; 2009; 6(4):195-204. PubMed ID: 19656996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs as potential investigative and predictive biomarkers in colorectal cancer.
    Yaghoubi N; Zahedi Avval F; Khazaei M; Aghaee-Bakhtiari SH
    Cell Signal; 2021 Apr; 80():109910. PubMed ID: 33387618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of miRNAs in colorectal cancer progression and chemoradiotherapy.
    Zhang N; Hu X; Du Y; Du J
    Biomed Pharmacother; 2021 Feb; 134():111099. PubMed ID: 33338745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissecting miRNA signature in colorectal cancer progression and metastasis.
    Huang X; Zhu X; Yu Y; Zhu W; Jin L; Zhang X; Li S; Zou P; Xie C; Cui R
    Cancer Lett; 2021 Mar; 501():66-82. PubMed ID: 33385486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
    Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y
    Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of miRNA in Colorectal Cancer Progression and Its Liver Metastases.
    Balacescu O; Sur D; Cainap C; Visan S; Cruceriu D; Manzat-Saplacan R; Muresan MS; Balacescu L; Lisencu C; Irimie A
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal Cancer.
    Soleimani A; Rahmani F; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
    Curr Pharm Des; 2018; 24(39):4605-4610. PubMed ID: 30636581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A panel of microRNA signature in serum for colorectal cancer diagnosis.
    Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.